MedPath

PHILLIP BRIAN SMITH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:7

Trial Phases

1 Phases

Phase 1:8

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
8 (100.0%)

PK Study With Pantoprazole in Obese Children and Adolescents

Phase 1
Completed
Conditions
Gastroesophageal Reflux Disease
Interventions
First Posted Date
2014-07-10
Last Posted Date
2019-09-17
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
41
Registration Number
NCT02186652
Locations
🇺🇸

University of Arkansas, Little Rock, Arkansas, United States

🇺🇸

Children's Mercy Hospital, Kansas City, Missouri, United States

🇺🇸

East Carolina University, Greenville, North Carolina, United States

and more 1 locations

Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile

Phase 1
Completed
Conditions
Bacterial Infections
Obesity
Interventions
First Posted Date
2012-12-07
Last Posted Date
2016-11-29
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
22
Registration Number
NCT01744730
Locations
🇺🇸

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

🇺🇸

Children's Mercy Hospital, Kansas City, Kansas, United States

🇺🇸

University of Louisville, Louisville, Kentucky, United States

and more 1 locations

Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)

Phase 1
Completed
Conditions
Systemic Infection
Interventions
First Posted Date
2012-11-19
Last Posted Date
2023-07-27
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
63
Registration Number
NCT01728363
Locations
🇺🇸

University of FL, Gainesville, Florida, United States

🇺🇸

UFL Health and Baptist, Jacksonville, Florida, United States

🇺🇸

Emory University, Atlanta, Georgia, United States

and more 7 locations

Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants

Phase 1
Withdrawn
Conditions
Sepsis
Interventions
Drug: Ticarcillin-clavulanic acid
First Posted Date
2010-10-27
Last Posted Date
2012-11-14
Lead Sponsor
Phillip Brian Smith
Registration Number
NCT01229046
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)

Phase 1
Completed
Conditions
Neonatal Sepsis
Herpes Simplex Virus
Interventions
First Posted Date
2009-07-20
Last Posted Date
2019-01-08
Lead Sponsor
Phillip Brian Smith
Target Recruit Count
32
Registration Number
NCT00942084
Locations
🇺🇸

Wesely Medical Center, Wichita, Kansas, United States

🇺🇸

Tulane School of Medicine, New Orleans, Louisiana, United States

🇺🇸

Duke University, Durham, North Carolina, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.